艾皮赛普特(EPCT)

%

简介:Immune Pharmaceuticals Inc.于1993年3月在特拉华州成立。该公司是一家公开上市的临床阶段性质的生物制药公司,专门从事开发和有针对性的治疗,包括单克隆抗体,单克隆抗体或纳米疗法和抗体药物共轭物的商业化,用于治疗的炎性疾病和癌症。


公司网站:
公司地址:550 Sylvan Avenue Englewood Cliffs NJ 07632
公司电话:1-201-4642677
今开:昨收:
最高:最低:
涨停价:跌停价:
总市值:0

艾皮赛普特的最新讨论

艾皮赛普特的公告

公告

$艾皮赛普特(EPCT)$ 8-K - Current report Filed: 2019-03-08 AccNo: 0001144204-19-013042 Size: 71 KBItem 1.03: Bankruptcy or ReceivershipItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Ce...

公告

$艾皮赛普特(EPCT)$ 8-K - Current report Filed: 2019-02-14 AccNo: 0001144204-19-008109 Size: 44 KBItem 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet ArrangementItem 9.01: Financial Statements and E...

公告

$艾皮赛普特(EPCT)$ 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities Filed: 2019-01-08 AccNo: 0001354457-19-000019 Size: 4 KB 网页链接

公告

$艾皮赛普特(EPCT)$ 8-K - Current report Filed: 2018-12-19 AccNo: 0001144204-18-065407 Size: 35 KBItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 5.07: Submission of Matters to a Vote of Security HoldersItem 9.01: Financial Statements an...

公告

$艾皮赛普特(EPCT)$ 8-K - Current report Filed: 2018-12-19 AccNo: 0001144204-18-065407 Size: 35 KBItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 5.07: Submission of Matters to a Vote of Security HoldersItem 9.01: Financial Statements an...